Heron Therapeutics HRTX 深 沪
等待开盘 11-04 09:30:00 美东时间
1.18
+0.020
+1.72%
华盛通- 最 高1.28
- 今 开1.18
- 成交量 492.15万股
- 最 低 1.09
- 昨 收 1.16
- 总市值 2.16亿
- 52周最高 2.68
- 市盈率 静 --
- 换手率 2.69%
- 52周最低 1.04
- 委 比 97.04%
- 总股本 1.83亿
- 历史最高 42.90
- 量 比 2.84
- 振 幅 16.38%
- 历史最低 0.16
- 每 手 1
- 风险率 0.38%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Heron Therapeutics Appoints Thomas Cusack to Board
Heron Therapeutics ( ($HRTX) ) has issued an update. On October 27, 2025, Heron...
10-30 04:48
Heron Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
Heron Therapeutics will hold a conference call and webcast on November 4, 2025, at 8:30 a.m. ET to discuss Q3 2025 financial results and recent business highlights. Participants can access the call via a registration link or through Heron's website under the Investor Relations section. An archive will be available post-call. Heron is a biotech company focused on improving patient care through innovative therapeutic developments.
10-21 20:20
Heron Therapeutics Approves Stock Issuance Proposals
Heron Therapeutics ( ($HRTX) ) has issued an announcement. On October 13, 2025,...
10-16 04:29
Heron Therapeutics Signs New Headquarters Lease
Heron Therapeutics ( ($HRTX) ) has shared an update. Heron Therapeutics, Inc. h...
08-29 05:30
HeartCore Regains Compliance with Nasdaq Minimum Stockholders’ Equity Requirement
HeartCore Enterprises Inc., a leading enterprise software and consulting services company, announced that it has regained compliance with the $2.5 million minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market. This determination was based on the company’s June 30, 2025, quarterly report, which reported stockholders’ equity of $3,559,017. HeartCore provides SaaS solutions, data analytics services, customer exp...
08-28 12:30
Heron Therapeutics Adopts Tax Benefit Preservation Plan
The latest announcement is out from Heron Therapeutics ( ($HRTX) ). On August 1...
08-15 20:24
Heron Therapeutics Signs Agreement with Patheon
An announcement from Heron Therapeutics ( ($HRTX) ) is now available. On August...
08-13 05:12
美股大行评级 | 潜在涨幅286.44%！RBC Capital上调Edgewise Therapeutics目标价至49美元，维持"跑赢大市"评级
今日重点评级关注：RBC Capital：维持Edgewise Therapeutics"跑赢大市"评级，目标价从48美元升至49美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从6美元升至7美元
08-11 09:43
Needham Maintains Buy on Heron Therapeutics, Lowers Price Target to $3
Needham analyst Serge Belanger maintains Heron Therapeutics (NASDAQ:HRTX) with a Buy and lowers the price target from $4 to $3.
08-09 03:01
